4.45 USD
▲+0.07+2.06%
盘后 4.48 +2.75%
2026-08-03
市值
$85.32M
市盈率
—
EPS
-1.78
股息率
—
52 周区间
3.06 – 5.73
成交量
165.85K
Beta
1.40
目标价
12.00
52W 低 3.0652W 高 5.73
价格走势
公司简介
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral ca...